Dr. Gary Ulaner elected President of the Society of Nuclear Medicine and Molecular Imaging Congratulations to LBCA Scientific Advisory Board member, Dr. Gary Ulaner on […]
New Local Advocacy Team Launches in Michigan! LBCA’s fourth Local Advocacy Team (LAT) has launched in Michigan and will be run by LBCA LAT Ambassadors
New Local Advocacy Team Launches in Michigan! Read More »
Thanks to the $1 Million gift made by Dr. Shannon Klingman, physician, lobular breast cancer survivor, and founder of Lume Deodorant, LBCA has launched a
Members of the Lobular Breast Cancer Alliance community, I am Bob McDevitt, Chair of the LBCA Board of Directors, writing on behalf of the Board
Exciting Opportunity to Explore a Role on the LBCA Board of Directors Read More »
Participation in clinical trials is one way that patients who are affected by ILC can help advance the understanding of lobular breast disease. These are
New ILC Clinical Trials Now Open Read More »
LBCA is proud to announce we’ve issued another ILC research grant solicitation. The LBCA Early Investigator Invasive Lobular Carcinoma Research Grant solicitation was just issued
The Lobular Breast Cancer Alliance and Susan G. Komen are excited to announce the grant recipients of the Susan G. Komen-Lobular Breast Cancer Alliance Metastatic
LBCA Patient Advocates Jade Moran and Janice Axelrod recently interviewed LBCA’s 2 newest Scientific Advisory Board Members Jade Moran interviewed new SAB Member Dr. Pooja Advani,
METAvivor, in partnership with LBCA is launching a new virtual peer-to-peer support group specifically for individuals living with Stage IV metastatic invasive lobular carcinoma (mILC).
New Metastatic ILC Support Group through Metavivor and LBCA Read More »
Lobular breast cancer and LBCA advocacy was more visible than ever before at this year’s San Antonio Breast Cancer Symposium (Dec. 9–12, 2025), the largest,
LBCA and ILC Research at SABCS 2025: Advancing Lobular Research Together Read More »
A Year of Hope for Lobular Breast Cancer We are thankful t o the entire LBCA community for the hard work and dedication towards our
A Year of Hope for Lobular Breast Cancer: FY25 Annual Report Read More »
LBCA invites you this first session of a four part series on liquid biopsy/CtDNA tests and relevance for ILC. In this first session, clinician/researchers Drs.
Liquid Biopsy Webinar Series: Overview of Liquid Biopsy Testing and Relevance for ILC Read More »
LBCA is pleased to announce that through a new collaboration between LBCA and Breast Cancer Research Foundation (BCRF) and through AACR, which has helped LBCA
LBCA, BCRF and AACR fund ILC Career Development ILC Research Grant Solicitation Read More »
2nd Annual Global Lobular Breast Cancer Awareness Day October 15th, 2025 As part of Breast Cancer Awareness month, October 15th is designated as Global Lobular
Join the Movement on October 15th to Raise Awareness of Lobular Breast Cancer Read More »
In honor of the 15% of breast cancer diagnoses that are lobular, we’ve set a goal to raise $150K for more ILC research during Breast
"*" indicates required fields